RCM
CDMO

Rotella Capital Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Rotella Capital Management’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-3,610
Closed -$33K – 679
2015
Q2 		$33K Buy
+3,610
New +$34.7K 0.03% 397
2014
Q4 		– Sell
-2,967
Closed -$28K – 446
2014
Q3 		$28K Buy
+2,967
New +$33.2K 0.03% 281

Other funds holding CDMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FIM
Freedom Investment Management Hartford, Connecticut $337M AUM 22.95% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SGAM
Smith Group Asset Management Dallas, Texas $2.46B AUM 57.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Rotella Capital Management's CDMO Position: Q3 2015 in Review

Rotella Capital Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q3 2015, closing a stake of 3,610 shares — an estimated $33K sold.

Rotella Capital Management first reported a position in CDMO in Q3 2014 and held it in 2 quarters. The position peaked at $33K in Q2 2015. 83 funds tracked by Wall St. Rank hold CDMO as of Q3 2015.

  • Rotella Capital Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q3 2015 after selling out during the quarter.
  • Rotella Capital Management sold 3,610 Avid Bioservices, Inc. Common Stock shares in Q3 2015, an estimated $33K.
  • Rotella Capital Management first reported a position in Avid Bioservices, Inc. Common Stock in Q3 2014 and held it in 2 quarters.
  • Rotella Capital Management's Avid Bioservices, Inc. Common Stock position peaked at $33K in Q2 2015.
  • 83 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q3 2015.

Based on Rotella Capital Management's 13F filing for Q3 2015, filed 13 Nov 2015.